Insider · CIK 0001351779

KIDRON NADAV

Reports to the SEC for 4 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001351779

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-24	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+349K sh	—	—	3,771,740
2026-09-24	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+369K sh	—	—	4,140,505
2026-09-24	ORMPORAMED PHARMACEUTICALS INC. · Stock option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−197K sh	—	—	0
2026-09-24	ORMPORAMED PHARMACEUTICALS INC. · Stock option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−190K sh	—	—	0
2026-09-24	ORMPORAMED PHARMACEUTICALS INC. · Stock option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−49K sh	—	—	0
2026-09-24	ORMPORAMED PHARMACEUTICALS INC. · Stock option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−97K sh	—	—	0
2026-09-24	ORMPORAMED PHARMACEUTICALS INC. · Stock option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−150K sh	—	—	0
2026-09-24	ORMPORAMED PHARMACEUTICALS INC. · Stock option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−107K sh	—	—	0
2026-08-21	NNDMNano Dimension Ltd.X Exercise of In-Money	Director	XExercise of In-Money	−10K sh	$1.50	−$15K	30,000
2026-08-21	NNDMNano Dimension Ltd. · Call options (obligation to sell)X Exercise of In-Money	Director	XExercise of In-Money	−100 sh	—	—	0
2026-03-30	ORMPORAMED PHARMACEUTICALS INC.F Tax Payment	Director, President and CEO	FTax Payment	−44.8K sh	$3.31	−$148K	3,422,243
2026-03-25	LFWDLifeward Ltd.A Award	Director	AAward	+7,657 sh	—	—	7,657
2026-03-17	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+167K sh	—	—	3,422,243
2026-03-12	ORMPORAMED PHARMACEUTICALS INC.G Gift	Director, President and CEO	GGift	−100K sh	—	—	3,255,238
2026-01-22	ORMPORAMED PHARMACEUTICALS INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+109K sh	—	—	3,355,238
2026-01-22	ORMPORAMED PHARMACEUTICALS INC. · Performance Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−109K sh	—	—	0
2025-12-31	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+233K sh	—	—	2,919,238
2025-12-31	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+327K sh	—	—	3,246,238
2025-12-31	ORMPORAMED PHARMACEUTICALS INC. · Performance Stock UnitsA Award	Director, President and CEO	AAward	+109K sh	—	—	109,000
2025-02-11	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+141K sh	—	—	2,400,598
2025-02-11	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+186K sh	—	—	2,586,598
2025-02-11	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+100K sh	—	—	2,686,598
2025-01-02	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+434K sh	—	—	2,259,598
2024-11-07	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+45K sh	—	—	1,826,098
2024-01-04	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+329K sh	—	—	1,781,098
2023-05-26	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+120K sh	—	—	1,452,098
2023-04-17	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+279K sh	—	—	1,332,098
2023-03-16	ORMPORAMED PHARMACEUTICALS INC.P Purchase	Director, President and CEO	PPurchase	+26K sh	$2.04	+$53K	126,000
2023-03-14	ORMPORAMED PHARMACEUTICALS INC.P Purchase	Director, President and CEO	PPurchase	+100K sh	$2.01	+$201K	100,000
2022-10-27	ORMPORAMED PHARMACEUTICALS INC.G Gift	Director, President and CEO	GGift	−25K sh	—	—	1,053,098
2022-08-01	ORMPORAMED PHARMACEUTICALS INC.F Tax Payment	Director, President and CEO	FTax Payment	−12.6K sh	$8.36	−$106K	1,078,098
2022-07-28	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+34K sh	—	—	964,729
2022-07-28	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+126K sh	—	—	1,090,729
2022-01-03	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+150K sh	—	—	916,481
2022-01-03	ORMPORAMED PHARMACEUTICALS INC.F Tax Payment	Director, President and CEO	FTax Payment	−48.8K sh	$13.89	−$677K	867,729
2022-01-03	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+63K sh	—	—	930,729
2022-01-03	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buyA Award	Director, President and CEO	AAward	+107K sh	—	—	107,000
2022-01-03	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+150K sh	—	—	936,481
2022-01-03	ORMPORAMED PHARMACEUTICALS INC.F Tax Payment	Director, President and CEO	FTax Payment	−48.8K sh	$13.89	−$677K	887,729
2022-01-03	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+63K sh	—	—	950,729
2022-01-03	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buyA Award	Director, President and CEO	AAward	+107K sh	—	—	107,000
2021-12-30	ORMPORAMED PHARMACEUTICALS INC.G Gift	Director, President and CEO	GGift	−20K sh	—	—	766,481
2021-12-28	ORMPORAMED PHARMACEUTICALS INC.F Tax Payment	Director, President and CEO	FTax Payment	−31.7K sh	$12.98	−$412K	786,481
2021-12-03	ORMPORAMED PHARMACEUTICALS INC.G Gift	Director, President and CEO	GGift	−20K sh	—	—	818,209
2021-08-31	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+100K sh	—	—	748,573
2021-08-31	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, President and CEO	AAward	+100K sh	—	—	838,209
2021-08-09	ORMPORAMED PHARMACEUTICALS INC.S Sale	Director, President and CEO	SSale	−220K sh	$20.11	−$4.42M	648,573
2021-08-09	ORMPORAMED PHARMACEUTICALS INC.S Sale	Director, President and CEO	SSale	−220K sh	$20.11	−$4.42M	738,209
2021-02-03	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+150K sh	—	—	150,000
2020-01-08	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+190K sh	—	—	190,000

Recent filings

Accepted (ET)
Sep 254
KIDRON NADAV0001213900-26-103540
SEC(opens sec.gov)
Aug 254
KIDRON NADAV0001104659-26-100937
SEC(opens sec.gov)
Mar 314
KIDRON NADAV0001213900-26-037447
SEC(opens sec.gov)
Mar 274
KIDRON NADAV0001178913-26-001814
SEC(opens sec.gov)
Mar 184
KIDRON NADAV0001213900-26-031013
SEC(opens sec.gov)
Mar 164
KIDRON NADAV0001213900-26-028291
SEC(opens sec.gov)
Jan 294
KIDRON NADAV0001213900-26-009479
SEC(opens sec.gov)
Jan 54
KIDRON NADAV0001213900-26-001280
SEC(opens sec.gov)
Feb 114
KIDRON NADAV0001213900-25-012239
SEC(opens sec.gov)

Companies

Address

1185 AVENUE OF THE AMERICAS THIRD FLOOR

NEW YORK, NY, 10036